Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion
Clinical trial NCT01674647 · COMPLETED
Trial details
- NCT number
- NCT01674647
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-01-01
- Enrollment
- 1504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.